Herpes Virus Infections in Kidney Transplant Patients

NCT05604911 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2025-04-06

No results posted yet for this study

Summary

Kidney transplant recipients are at increased risk of infections, including Varicella-zoster virus (VZV) infections. Vaccination against VZV is routinely offered to all kidney transplant recipients and candidates in Denmark. In this exploratory observational study, the VZV specific immune response in kidney transplant candidates and recipients will be characterized at different time points in relation to transplantation, vaccination and infections. More knowledge on the immune reaction to transplantation, VZV vaccination and VZV infections may provide improved strategies for prevention and treatment of VZV infections in kidney transplant candidates and recipients.

Conditions

  • Kidney Transplant; Complications
  • Varicella Zoster Virus Infection
  • Vaccine-Preventable Diseases

Sponsors & Collaborators

  • Technical University of Denmark

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Susanne Dam Nielsen, MD, DMSc

    lead OTHER

Principal Investigators

  • Susanne D Nielsen, MD, DMSc · Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

  • Søren S Sørensen, MD, DMSc · Department of Nephrology, Copenhagen University Hospital - Rigshospitalet

  • Claus Bistrup, MD, PhD · Department of Nephrology, Odense University Hospital

  • Henrik Birn, MD, PhD, DMSc · Department of Nephrology, Aarhus University Hospital

  • Sine R Hadrup, MSc, PhD · Department of Health Technology, Technical University of Denmark

  • Annemette Hald, RN · Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

  • Sunil K Saini, MSc, PhD · Department of Health Technology, Technical University of Denmark

  • Isik S Johansen, MD, DMSc · Department of Infectious Diseases, Odense University Hospital

  • Helle Bruunsgaard, MD, PhD, DMSc · Department of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet

  • Carsten S Larsen, MD, DMSc · Department of Infectious Diseases, Aarhus University Hospital

  • Zitta B Harboe, MD, PhD · Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital - North Zealand

  • Moisés A Suarez Zdunek, MD · Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

  • Sebastian R Hamm, BSc.med. · Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05604911 on ClinicalTrials.gov